An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China
Clinical trial NCT07604766 · RECRUITING
Trial details
- NCT number
- NCT07604766
- Sponsor
- Genmab
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2027-09-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.